MARKET PULSE-Endocyte, Sonic, Exelixis, G-III Apparel, Arlington
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures edged higher on Tuesday, implying a modest rebound off the previous session's decline, though investors continued to watch global issues with caution. Dow Jones industrial average futures were up 0.14 percent at 16,224, S&P 500 futures were up 0.44 percent at 1,857.5 and Nasdaq 100 futures were up 0.44 percent at 3,627.
** SONIC CORP, Monday close $20.92, +6.12 pct premarket
The drive-in restaurant operator, on Monday, reported a better-than-expected second-quarter profit, helped by a 1.4 percent rise in its same-store sales.
At least four brokerages increased their price targets on the restaurant chain's stock.
** EXELIXIS INC, Monday close $6.27, +6.86 pct premarket
The drug developer said the European Commission granted conditional approval to its cancer drug, Cometriq, as a treatment for patients with medullary thyroid cancer.
The company said its partner, Swedish Orphan Biovitrum , would support marketing of the drug in the European Union through the end of 2015. Continued...